Govt Job: For Research Assistant at NIB

The National Institute of Biological Sciences (NIB) had been set up in 1992. NIB is an apex autonomous institute under the administrative control of the Ministry of Health and Family Welfare (MoHFW), Government of India.

The Institute is performing the primary statutory function of Quality Control of Biologicals e.g. Insulin, erythropoietin, blood products, diagnostic kits e.g. HIV, HBV, HCV, therapeutic monoclonal antibodies like Trastuzumab and Rituximab used in cancer treatment, etc. in accordance with provisions of Drugs & Cosmetics Act 1940 and Rule 1945 amended from time to time.

Walk-in interview for the post of Research Assistant in an ICMR funded project at NIB.

Post: Research Assistant

No of Posts: 01

Age: Maximum age limit 30 years

Duration: 01 year

Name of the Project: “Development of in vitro bioassay for the biological activity of anti-HER2 therapeutic monoclonal antibodies based on variability in the expression of HER2 in breast cancer cell lines”.

Qualification & Experience :
Essential Qualification: Master’s degree in Life Science / Biotechnology from a recognized university with a minimum of 60% marks secured.

Desirable: • Hands-on experience in animal cell culture, nucleic acid extraction, and PCR.

Remuneration: Rs. 31,000 per month, fixed.

Interested candidates are requested to attend the walk-in interview as per the following schedule.

Candidates coming for an interview should bring a CV, a recent passport-size photograph, originals as well copy of the certificates and documents, and other testimonials to support the claim of experience, etc.

Date of Interview:15.12.2022
Time: 11:00 am

Place of Interview: Conference Hall,  2nd Floor, Admin Block, NIB, A-32, Sector-62, NOIDA.

General Instruction :

1. The competent Authority reserves the right to make any amendment, cancellation or changes in this advertisement in whole or in part without assigning any reason.

2. The appointment will be for one year and extendable for another two years depending on the availability of the funds.

3. The post is temporary in nature and the appointment can be terminated by giving not less than one month’s notice on either side at any time.

4. No TA/DA will be paid for attending the interview.

The competent Authority reserves the right to reject any call or all applications received without assigning any reasons or giving notice.

Related Posts

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

New Delhi: Serious legal gaps in the Drugs and Cosmetics Act, 1940, combined with acute shortages of manpower and infrastructure, continue to impede the Central Drugs Standard Control Organisation (CDSCO)…

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

Patna: In a significant ruling that could have far-reaching implications for NDPS drug-related prosecutions involving common pharmaceutical compounds, the Patna High Court has held that Phenothiazine and Promethazine do not…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines